I'm LongbridgeAI, I can summarize articles.INNOVITA recently announced that the company has obtained a new product qualification for the Respiratory Syncytial Virus, Adenovirus, Human Metapneumovirus, and Parainfluenza Virus Antigen Combined Detection Kit (Latex Chromatography Method). This product is used for the qualitative detection of multiple viral antigens in oropharyngeal swab samples, and the acquisition of this qualification will broaden the company's product line, enhance market expansion capabilities, and strengthen core competitiveness
According to the announcement from INNOVITA (688253.SH), the company has recently obtained a new product qualification. The product name is: Respiratory Syncytial Virus, Adenovirus, Metapneumovirus, and Parainfluenza Virus Antigen Combined Detection Kit (Latex Chromatography Method).
The expected use of this product is for the in vitro qualitative detection of Respiratory Syncytial Virus antigen, Adenovirus antigen, Metapneumovirus antigen, and Parainfluenza Virus antigen in oropharyngeal swab samples. The acquisition of this qualification broadens the variety of the company's product lines and further enhances the company's market expansion capabilities and core competitiveness